Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist
Open Access
- 1 April 2010
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 298 (4), R1098-R1110
- https://doi.org/10.1152/ajpregu.00326.2009
Abstract
The mechanism and route whereby glucagon-like peptide 1 (GLP-1) receptor agonists, such as GLP-1 and exendin-4 (Ex-4), access the central nervous system (CNS) to exert their metabolic effects have yet to be clarified. The primary objective of the present study was to investigate the potential role of two circumventricular organs (CVOs), the area postrema (AP) and the subfornical organ (SFO), in mediating the metabolic and CNS-stimulating effects of Ex-4. We demonstrated that electrolytic ablation of the AP, SFO, or AP + SFO does not acutely prevent the anorectic effects of Ex-4. AP + SFO lesion chronically decreased food intake and body weight and also modulated the effect of Ex-4 on the neuronal activation of brain structures involved in the hypothalamic-pituitary-adrenal axis and glucose metabolism. The results of the study also showed that CVO lesions blunted Ex-4-induced expression of c- fos mRNA (a widely used neuronal activity marker) in 1) limbic structures (bed nucleus of the stria terminalis and central amygdala), 2) hypothalamus (paraventricular hypothalamic nucleus, supraoptic nucleus, and arcuate nucleus), and 3) hindbrain (lateral and lateral-external parabrachial nucleus, medial nucleus of the solitary tract, and ventrolateral medulla). In conclusion, although the present results do not support a role for the CVOs in the anorectic effect induced by a single injection of Ex-4, they suggest that the CVOs play important roles in mediating the actions of Ex-4 in the activation of CNS structures involved in homeostatic control.Keywords
This publication has 61 references indexed in Scilit:
- Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in RatsDiabetes, 2009
- Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nucleiJournal of Chemical Neuroanatomy, 2008
- Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food IntakeDiabetes, 2008
- Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stressExperimental Neurology, 2008
- Neuropeptide Y in normal eating and in genetic and dietary-induced obesityPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2006
- Effects of the biliopancreatic diversion on energy balance in the ratInternational Journal of Obesity, 2005
- The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathwayBrain Research, 2005
- C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 typeJournal of Neuroimmunology, 1996
- Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in manDigestive Diseases and Sciences, 1993
- Area postrema/nucleus of the solitary tract ablations: Analysis of the effects of hypophagiaPhysiology & Behavior, 1984